ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants

ClinicalTrials.gov ID: NCT01819064

Public ClinicalTrials.gov record NCT01819064. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 4:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Do Small Doses of Atropine Cause Bradycardia in Young Children

Study identification

NCT ID
NCT01819064
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
State University of New York at Buffalo
Other
Enrollment
60 participants

Conditions and interventions

Interventions

  • Atropine Drug

Drug

Eligibility (public fields only)

Age range
1 Day to 2 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2013
Primary completion
Jun 30, 2013
Completion
Jun 30, 2013
Last update posted
Apr 5, 2023

2013

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Women and Children's Hospital of Buffalo Buffalo New York 14222

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01819064, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2023 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01819064 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →